Review, approval, and marketing of biosimilars in the United States - Part 1: Safety and regulatory issues

Amber W. Aagaard, Serena Purdy, Sean Philpott

Research output: Contribution to Newspaper/Magazine/Website › Article

Cite this

@misc{e7dd26cf1fb749e2beb606239c6ef855,

title = "Review, approval, and marketing of biosimilars in the United States - Part 1: Safety and regulatory issues",

author = "Aagaard, {Amber W.} and Serena Purdy and Sean Philpott",

year = "2010",

month = dec,

language = "English",

volume = "8",

pages = "12--20",

journal = "BioProcess International",

issn = "1542-6319",

publisher = "PJB Publications Ltd.",

}

TY - GEN

T1 - Review, approval, and marketing of biosimilars in the United States - Part 1

T2 - Safety and regulatory issues

AU - Aagaard, Amber W.

AU - Purdy, Serena

AU - Philpott, Sean

PY - 2010/12

Y1 - 2010/12

UR - http://www.scopus.com/inward/record.url?scp=78650346632&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:78650346632

VL - 8

SP - 12

EP - 20

JO - BioProcess International

JF - BioProcess International

SN - 1542-6319

ER -